CVRx was founded in 2001 with the mission to improve the lives of patients suffering from high blood pressure and heart failure. The company has since become a leader in the medical device industry, with its revolutionary Barostim technology changing the landscape of cardiovascular treatment.
Barostim is a minimally invasive device that is implanted in the chest and connected to the carotid artery. This innovative technology triggers the body's natural blood flow regulation system, providing a safe and effective treatment for patients with high blood pressure and heart failure.
The impact of CVRx's technology on patients' lives is truly remarkable. Many patients have reported significant improvements in their symptoms, including decreased blood pressure and increased energy levels. These patient stories serve as a testament to the effectiveness of Barostim and the commitment of CVRx to improving patient outcomes.